Blood tests are probably the most powerful indicator of health – good or bad – and can point towards therapy required. EU funding has helped develop a revolutionary mobile point-of-care blood analysis and diagnostic unit.
From a simple haemoglobin reading to a new biomarker for cancer or expression of a certain gene, blood tests can accurately indicate disease progression. To date, their full potential has been hampered by slow and costly analysis, in part due to large immobile in vitro diagnostic (IVD) equipment.
Further details: A significant boost for portable blood diagnostics technology